Biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis [1]

Diabetic Medicine

Volumn 18, Issue 12, 2001, Pages 1007-1008

  Chan, N N ^a   Hurel, S J ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MANNITOL; PROTEIN S 100;

BRAIN EDEMA; CENTRAL PONTINE MYELINOLYSIS; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPONATREMIA; HYPOXIA; ION TRANSPORT; LETTER; PATHOGENESIS; PLASMA OSMOLALITY; PROGNOSIS; RESPIRATORY ARREST; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; BRAIN EDEMA; DIABETIC KETOACIDOSIS; HUMANS; NERVE GROWTH FACTORS; S100 PROTEINS;

EID: 0035669626     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00532.x     Document Type: Letter

References (9)

1. Serum S-100β protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis
2. Intracerebral crises during treatment of diabetic ketoacidosis
3. Subclinical brain swelling in children during treatment of diabetic ketoacidosis
4. Detection of subclinical brain dysfunction by sensory evoked potentials in patients with severe diabetic ketoacidosis
5. Cerebral oedema in diabetic ketoacidosis
6. Cerebral oedema with irreversible coma in severe diabetic ketoacidosis
7. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis
8. Cerebral oedema complicating therapy for diabetic ketoacidosis
9. Fatal cerebral oedema associated with hyponatraemia in adult diabetic ketoacidosis